---
title: Track to Train
description: GEM Premier 7000, when connected to GEMweb® Plus 500 Custom Connectivity, can help identify where training is required, to help lower preanalytical errors.
---

![h1-hero-img](https://hemolysisdetection.werfen.com/hubfs/h1-hero-img.svg)

# Illuminate weak spots. Mitigate errors.

With Track-to-Train expertise

![image](https://hemolysisdetection.werfen.com/hs-fs/hubfs/image.jpg?width=470&height=398&name=image.jpg)

## Hemolysis can lead to delayed care and inappropriate patient management.1

GEM Premier 7000* with iQM3 provides lab-quality hemolysis detection at the point of care.2 When connected to GEMweb® Plus 500 Custom Connectivity, it can identify where training is required throughout the hospital, to help lower preanalytical errors, including hemolysis.

![card-img-2](https://hemolysisdetection.werfen.com/hs-fs/hubfs/card-img-2.jpg?width=1012&height=795&name=card-img-2.jpg) ![](https://hemolysisdetection.werfen.com/hubfs/raw_assets/public/werfen-theme/assets/images/image-bg-circles.svg)

## Track-to-Train to better outcomes

GEMweb Plus 500 Custom Connectivity helps identify locations and operators where hemolysis and other preanalytical error rates are high. It provides a Sample Handling Report that uncovers competency gaps and training needs for improved sample quality. Hospitals can then rely on Werfen Academy to help train operators on strategies to improve preanalytical quality.

[Request an example Sample Handling Report **](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIwHaWHtarB8cMd7pWNcawF1xxBfNpgYFe69kdfmXlwt1bwyLGhxUNZOpEZnC61NNDuP662Qf57Jb8ls2zNlFcT1nzeW6rG7U2qMPzXpSsBE6S19knDZ%2BXbebuD0Ug205htxk9TPuh8H80hJA1zAZZR0431qV8PHqf2l69nJMD7TlKeUrKhVoc25lfYHVSqWmEXV%2B1KUcBUXQ%3D%3D&webInteractiveContentId=189906828301&portalId=8318686)

![woman-smiling](https://hemolysisdetection.werfen.com/hs-fs/hubfs/woman-smiling.jpg?width=507&height=398&name=woman-smiling.jpg) ![](https://hemolysisdetection.werfen.com/hubfs/raw_assets/public/werfen-theme/assets/images/image-bg-circles.svg)

## Learn from industry experts on Werfen Academy

Lab and Clinical Managers can leverage Werfen Academy, an online learning portal, to provide continuing education and training. Staff can enhance their skills, test their knowledge, and receive certificates of completion. Available 24/7, healthcare professionals learn online, when it fits their schedule.

[Download information on Werfen Academy **](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLL4xQwBEhohVpljvegZ1t71UJMTkde0HaHu7cJsnUT6UMd%2FGVeplFYpHR%2FlyPfINUxcLYf4aMvdQB%2BfW67LQ%2F9u%2FucdMus7pgA6Gyg8SsJR%2BSDTuBikwz%2FtZ5xC%2Fy%2FCJivnYURRIllRMV%2FNJL%2BP7OvUb8yVOd2NpzFSi72EpONtjocoY159YKAiNu58aSriSYjgutGqrg19tE6bt8x3ggx7CmS1xlbHt%2FOtklFfHWhyQvKoh636IyRuZhLUGt%2B5TB%2B9RFbz4scAOzfUSw%2FNApcymfMRYbkMmfFq&webInteractiveContentId=189937120025&portalId=8318686)

## Centralized, comprehensive management technology

![Group 25460](https://hemolysisdetection.werfen.com/hs-fs/hubfs/Group%2025460.png?width=1689&height=186&name=Group%2025460.png)

GEMweb Plus 500 Custom Connectivity provides customizable connectivity and automated functionality for comprehensive management of systems and operators. Makes point-of-care testing oversight easy and flexible.

- Real-time remote management of system configuration without testing interruption
- Total automated management of operators with multilevel authorization and traceability of users, actions, and competence
- Single, unified database provides access to patient results
- Customizable to multiple connection types

![prod-displays](https://hemolysisdetection.werfen.com/hs-fs/hubfs/prod-displays.png?width=1174&height=684&name=prod-displays.png)

[![1. O’Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis or sample contamination on patient care and outcomes in point-of-care testing: a retrospective study. J Appl Lab Med. 2020;5(2):332-341. doi:10.1093/jalm/jfz020.  2. Phelan MP, Hustey FM, Good DM, Reineks EZ. Seeing red: blood sample hemolysis is associated with prolonged emergency department throughput. J Appl Lab Med. 2020;5(4):732–737. doi:10.1093/jalm/jfaa073.  3. Wilson M, Adelman S, Maitre JB, et al. Accuracy of hemolyzed potassium levels in the emergency department. West J Emerg Med. 2020;21(6):272–275. doi:10.5811/westjem.2020.8.46812.  4. Milutinović D, Andrijević I, Ličina M, Andrijević L. Confidence level in venipuncture and knowledge on causes of in vitro hemolysis among healthcare professionals. Biochem Med. 2015;25(3):401–409. doi:10.11613/BM.2015.040. ](https://no-cache.hubspot.com/cta/default/8318686/interactive-208967544415.png) ](https://hemolysisdetection.werfen.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKdv9a2MTwuD5WJi0IIS34dIexDNMVnHtcsyD1%2Faz8VipjLhXv53C7ofdHzB7lJD7UmOHp7X1EYb%2Fshyjrf6l2T76pI6BQ9rtxxirxtw02EjVo1ayDmV6YtBWsYBpDATU%2B9NNxWqdfaXKsZZEAIg6hDeN0KOL2Fj1Vh4eMxpMZTZMhdoFxIAsdS8lhV8Fv7AP%2B%2FrOReIEQRx5tqsw%3D%3D&webInteractiveContentId=208967544415&portalId=8318686&hsLang=en)

References

GEM, Premier, GEM Premier ChemSTAT, ChemSTAT, GEMweb, iQM, Hemochron, VerifyNow, Avoximeter, and ROTEM are trademarks of Instrumentation Laboratory Company (d.b.a. Werfen) and/or one of its subsidiaries or parent companies and may be registered in the United States Patent and Trademark Office and in other jurisdictions. The Werfen logo is a trademark of Werfen and may be registered in the Patent and Trademark Offices of jurisdictions throughout the world. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.

**©2025 Instrumentation Laboratory. All rights reserved.**

***Not available in all countries.**

**References:**

1. Phelan MP, Ramos C, Walker LE, et al. The hidden cost of hemolyzed blood samples in the emergency department. *J Appl Lab Med.* 2021;6(6):1607–1610. doi:10.1093/jalm/jfab035.
2. Balasubramanian S, McDowell EJ, Laryea ET, et al. Novel in-line hemolysis detection on a blood gas analyzer and impact on whole blood potassium results. *Clin Chem.* 2024;70(12):1485-1493. doi:10.1093/clinchem/hvae135.

© Copyright 2026 All Rights Reserved

![yield](https://hemolysisdetection.werfen.com/hs-fs/hubfs/yield.png?width=42&height=42&name=yield.png)

Please be advised that you are now leaving the Werfen Website. Links are provided as a convenience and for informational purposes only. Werfen bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

 https://resources.werfen.com https://info.werfen.com,https://autoimmunity.werfen.com,https://8318686.hs-sites.com https://hemolysisdetection.werfen.com/ https://hemolysisdetection.werfen.com, https://70series.werfen.com http://werfenacademy.com/ https://www.werfen.com http://share.hsforms.com/ http://8318686.fs1.hubspotusercontent-na1.net/ https://share.hsforms.com/2pQwTMp4XS2yuKMkFw7EHeg4yaqm?hsCtaAttrib=189939778984 https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect

Leave Site

Go Back